Banks cut pricing as Evonik syndication stumbles

The buyout loan backing Advent’s acquisition of Evonik’s methacrylates business has struggled in the first round of syndication, with leads increasing the OID and targeting the wide end of guidance.

  • By Owen Sanderson
  • 06 Jun 2019

The acquisition was agreed at the beginning of March, following an auction process begun last autumn. The business sells Plexiglas, and other related products, with manufacturing sites across Germany, North America and Asia.

GSO Capital offered staple financing to support the sale, in what would have been one ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 5,388.55 35 7.45%
2 Credit Agricole CIB 5,167.13 26 7.14%
3 Deutsche Bank 5,163.07 27 7.14%
4 Goldman Sachs 4,132.89 22 5.71%
5 JPMorgan 4,083.96 19 5.65%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 Deutsche Bank 2,970.40 18 8.44%
2 Citi 2,605.77 18 7.40%
3 BNP Paribas 2,567.12 24 7.29%
4 JPMorgan 2,467.56 18 7.01%
5 Goldman Sachs 1,928.73 16 5.48%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13,711.91 110 9.94%
2 Citi 12,738.91 102 9.24%
3 Goldman Sachs 9,904.15 73 7.18%
4 Bank of America Merrill Lynch 9,863.78 84 7.15%
5 Morgan Stanley 8,144.98 61 5.90%